ストックスクリーナーアプリを入手
27.20
3.82%
-1.08
プレマーケット:
27.58
0.38
+1.40%
前日終値:
$28.28
開ける：
$28.57
24時間の取引高:
1.36M
Relative Volume:
1.64
時価総額：
$1.63B
収益：
$439.00K
当期純損益:
$-105.64M
株価収益率:
-15.11
EPS:
-1.8
ネットキャッシュフロー:
$-60.70M
1週間 パフォーマンス:
+5.22%
1か月 パフォーマンス:
+16.19%
6か月 パフォーマンス:
-5.19%
1年 パフォーマンス:
-44.95%
1日の値動き範囲:
$27.02
$29.09
1週間の範囲:
$25.18
$29.09
52週間の値動き範囲:
$21.73
$71.71
Janux Therapeutics Inc Stock (JANX) Company Profile
名前
Janux Therapeutics Inc
セクター
電話
(858) 751-4493
住所
10955 VISTA SORRENTO PARKWAY, SAN DIEGO
JANX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
JANX
Janux Therapeutics Inc
|
27.20 | 1.55B | 439.00K | -105.64M | -60.70M | -1.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Janux Therapeutics Inc Stock (JANX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-17 | 開始されました | Barclays | Overweight |
| 2025-09-10 | 開始されました | Stifel | Buy |
| 2025-09-10 | 開始されました | Truist | Buy |
| 2025-09-04 | 開始されました | Guggenheim | Buy |
| 2025-08-19 | 開始されました | Piper Sandler | Overweight |
| 2025-07-11 | 開始されました | Raymond James | Outperform |
| 2024-12-03 | 繰り返されました | BTIG Research | Buy |
| 2024-12-03 | 繰り返されました | H.C. Wainwright | Buy |
| 2024-11-22 | 開始されました | Leerink Partners | Outperform |
| 2024-10-24 | 開始されました | UBS | Buy |
| 2024-09-06 | 開始されました | Stifel | Buy |
| 2024-05-30 | 開始されました | Scotiabank | Sector Perform |
| 2024-03-21 | 開始されました | BTIG Research | Buy |
| 2024-03-20 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-04-06 | 開始されました | Wedbush | Outperform |
| 2022-11-14 | 開始されました | William Blair | Outperform |
すべてを表示
Janux Therapeutics Inc (JANX) 最新ニュース
Can Janux Therapeutics Inc. stock surprise with earnings upsideForecast Cut & AI Forecast for Swing Trade Picks - newser.com
Real time alert setup for Janux Therapeutics Inc. performanceQuarterly Risk Review & Safe Capital Growth Trade Ideas - newser.com
Is Janux Therapeutics Inc. stock attractive for income investorsJuly 2025 Technicals & Community Trade Idea Sharing Platform - newser.com
Can trapped investors hope for a rebound in Janux Therapeutics Inc.Market Performance Report & Stock Portfolio Risk Control - newser.com
Is Janux Therapeutics Inc. stock poised for growthWeekly Loss Report & High Return Stock Watch Alerts - newser.com
Janux Therapeutics (JANX) Is Up 10.5% After Positive Pipeline Updates and Analyst EPS Revisions – Has the Bull Case Changed? - Sahm
Why Janux Therapeutics (JANX) Is Up 10.5% After Pipeline Progress Fuels Optimism for Prostate Cancer Therapies - Yahoo Finance
Janux Therapeutics (JANX) Surges 6.8%: Is This an Indication of Further Gains? - Yahoo Finance
Trend analysis for Janux Therapeutics Inc. this weekPortfolio Gains Report & Daily Growth Stock Investment Tips - newser.com
Stoke Therapeutics (STOK) Surges 11.7%: Is This an Indication of Further Gains? - Nasdaq
What drives Janux Therapeutics Inc stock priceEarnings Per Share Trends & Rapid Portfolio Gain - earlytimes.in
Weiss Ratings Reaffirms Sell (D-) Rating for Janux Therapeutics (NASDAQ:JANX) - MarketBeat
Visual trend scoring systems applied to Janux Therapeutics Inc.Market Movement Recap & Accurate Entry and Exit Point Alerts - newser.com
Janux Therapeutics (NASDAQ:JANX) Is In A Good Position To Deliver On Growth Plans - Sahm
Janux Therapeutics, Inc. (JANX) Stock Analysis: Exploring the 245% Upside Potential in Biotech - DirectorsTalk Interviews
How hedge fund analytics apply to Janux Therapeutics Inc. stockWeekly Trade Review & Capital Protection Trading Alerts - newser.com
Will a bounce in Janux Therapeutics Inc. offer an exitMarket Movement Recap & AI Enhanced Trading Signals - newser.com
How geopolitical tensions affect Janux Therapeutics Inc. stock2025 Momentum Check & Risk Controlled Stock Pick Alerts - newser.com
Janux Therapeutics Inc. recovery potential after sell offDollar Strength & Real-Time Volume Surge Alerts - newser.com
Leading vs lagging indicators on Janux Therapeutics Inc. performanceJuly 2025 Outlook & Community Supported Trade Ideas - newser.com
Janux Therapeutics Inc (JANX) Gets a Buy from Bank of America Securities - The Globe and Mail
BofA Securities Maintains Janux Therapeutics(JANX.US) With Buy Rating - 富途牛牛
What earnings revisions data tells us about Janux Therapeutics Inc.Recession Risk & Daily Profit Maximizing Tips - newser.com
Using data tools to time your Janux Therapeutics Inc. exitWeekly Trend Summary & High Accuracy Trade Signal Alerts - newser.com
Published on: 2025-10-03 01:15:11 - newser.com
Janux Therapeutics, Inc. (NASDAQ:JANX) Receives $78.31 Average PT from Brokerages - Defense World
Will Q4 Earnings Be a Catalyst for Jash Engineering LimitedDay Trading Setups & Affordable Investment Tips - earlytimes.in
Published on: 2025-09-29 03:27:23 - newser.com
Janux Therapeutics Inc (JANX) 財務データ
収益
当期純利益
現金流量
EPS
Janux Therapeutics Inc (JANX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Meyer Andrew Hollman | Chief Business Officer |
May 01 '25 |
Sale |
32.03 |
3,333 |
106,745 |
82,139 |
2.96%
0.09%
大文字化:
|
ボリューム (24 時間):